Synopsis : Researchers at the University of California in the US found that patients taking GLP-1 medications — the class of drugs that includes Ozempic, Wegovy, and Mounjaro — were less than half as likely to die within five years of a colon cancer diagnosis.

The blockbuster drugs that have revolutionised weight loss may have just revealed an unexpected superpower: Helping colon cancer patients survive.

In a discovery, researchers at the University of California in the US found that patients taking GLP-1 medications—the class of drugs that includes Ozempic, Wegovy, and Mounjaro—were less than half as likely to die within five years of a colon cancer diagnosis compared to those not using these medications.

Also Read: Obesity drugs set to dominate next 50 years of medicine

The number

See Full Page